The Australian Immunisation Handbook 10th Edition 2013

136 The Australian Immunisation Handbook 10th edition
Vaccines not routinely recommended in pregnancy
Inactivated bacterial vaccines Recommendation Comments
Haemophilus influenzae type b (Hib)
vaccine
Meningococcal conjugate vaccines
(MenCCV or 4vMenCV)
Meningococcal polysaccharide vaccine
(4vMenPV)
13-valent pneumococcal conjugate
vaccine (13vPCV)
Not routinely recommended
Can be given to pregnant women
at increased risk of Hib disease (e.g.
with asplenia)
Not routinely recommended
Can be given to pregnant women
at increased risk of meningococcal
disease (e.g. with asplenia) or
as post-exposure prophylaxis
in household contacts/cases of
meningococcal serogroup A, C, W 135
or Y
Not routinely recommended
Can be given to pregnant women
at increased risk of meningococcal
disease who have not been
vaccinated with 4vMenPV in the
past 3 years (e.g. with asplenia),
or as post-exposure prophylaxis
in household contacts/cases of
meningococcal serogroup A, W 135
or Y
Limited available data suggest that it is unlikely that use of Hib
vaccine in pregnant women has any deleterious effects on pregnancy
outcomes. 20
There are limited data on the safety of meningococcal conjugate
vaccines in pregnancy. 21 Where clinically indicated, meningococcal
conjugate vaccine can be given to pregnant women. 22
Limited available data suggest that it is unlikely that use of
meningococcal polysaccharide vaccine in pregnant women has
any deleterious effects on pregnancy outcomes. 23,24 Where clinically
indicated, meningococcal polysaccharide vaccine can be given to
pregnant women, although 4vMenCV is preferred. 22
Not routinely recommended No data are available. Vaccination during pregnancy has not been
evaluated, although is unlikely to result in adverse effects.